1 / 40

Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment Nationa

Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment National Cancer Institute. Richard Simon, D.Sc., Chief http://linus.nci.nih.gov/brb. DNA Microarray Technology.

jaden
Download Presentation

Biometric Research Branch Activities in DNA Microarray Investigations Division of Cancer Diagnosis and Treatment Nationa

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biometric Research Branch Activities in DNA Microarray InvestigationsDivision of Cancer Diagnosis and TreatmentNational Cancer Institute Richard Simon, D.Sc., Chief http://linus.nci.nih.gov/brb

  2. DNA Microarray Technology • Powerful tools for understanding mechanisms and enabling predictive medicine • Challenges ability of biomedical scientists to analyze and interpret data • Challenges mathematical scientists with new problems for which existing analysis paradigms are often inapplicable

  3. Difficulties Resulting from Inadequate Training and Organization for 21st Century Biomedicine • Hype • Excessive skepticism and inappropriate criticism • Mis-information • Amature statisticians • Professional statisticians not sufficiently involved in collaborative studies • Software that encourages invalid analysis • Developed by individuals who don’t know enough about statistical analysis of high dimensional data • Funded by decision makers who are floundering about how to organize to achieve the potential of bioinformatics and computational biology

  4. Involvement of Biometric Research Branch • Developmental Diagnostics Working Group • Courses in genomics • Biotechnology techniques (18 hrs lecture/20 hrs lab) • Recombinant DNA methodology I (18/20) • Advanced genome analysis (18/20) • DNA binding proteins and transcriptional regulators (18/20) • Cellular & molecular approaches to the study of cancer (18/20) • Cold Spring Harbor Course in Computational Genomics • Collaborations with Jeff Trent’s Laboratory of Cancer Genetics • Establishment of Molecular Statistics & Bioinformatics Section

  5. Collaborative research • Methodological research • Software development • MadB • BRB-ArrayTools • Training • BRB post-docs • CCR scientists

  6. BRB Collaboration with CCR on Microarray based Investigations • Joanna Shih, Ph.D. • Available for collaboration with CCR scientists on the analysis of genomic data (including micro-array analysis). Has supervised 2 post-docs working jointly with BRB & CCR • George Wright, Ph.D. • Collaborates intensively with Dr. Lou Staudt’s Laboratory and is the primary statistician in the Lymphoma Leukemia Molecular Profiling Project (LLMPP).

  7. Other BRB Staff Collaboration in Microarray Studies • Dr Paul Albert, serves as primary statistician for Urologic-oncology, Neuro-oncology, Pathology, Radiation oncology, Prevention, Metabolism branches • Dr. Dodd, Korn, McShane, Zhao & post-docs • No obligations to intramural program, but collaborate on selected studies, e.g. • With A Hildesheim, Rose Yang, Sophia Wang on gene disregulation in Nasal pharyngeal carcinoma and the mechanism of HPV carcinogenesis in cervical cancer • With T Ried, M Difilippantonio on whole genome expression and CGH analysis of human rectal carcinoma

  8. Collaboration with CCR on Microarray Studies • Rich Simon • Sandy Swain (human breast cancer) • Xin Wang (human hepatocellular cancer) • Jeff Green (mouse models of breast cancer) • Ed Liu, Rick Klausner, Marston Linnehan, Lanny Kirsh • Numerous consultations, eg Curt Harris, Snorri Thorgeirsson, Steve Zeichner, Pat Steeg, Howard Fine,…

  9. Classes & Workshops by BRB on Analysis of DNA Microarray Expression Profile Data • Monthly 4 hr class on statistical analysis of expression profiling data • Monthly 4 hr class on BRB-ArrayTools software • Full day workshops in which BRB statisticians consult with investigators on design and analysis of genomic data

  10. Use of BRB Website for Education of Biomedical Scientistshttp://linus.nci.nih.gov/brb • Reprints & Technical Reports • Powerpoint presentations • Audio files • BRB-ArrayTools software • Message board • BRB-ArrayTools Data Archive • Sample Size Planning for Targeted Clinical Trials

  11. DNA Microarray Methodology • Simon R, Korn E, McShane L, Radmacher M, Wright G, Zhao Y. Design and analysis of DNA microarray investigations, Springer-Verlag, 2004 • Simon R, Radmacher MD, Dobbin K. Design of studies with DNA microarrays. Genetic Epidemiology 23:21-36, 2002 • McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon R. Methods of assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 18:1462-1469, 2002 • Korn EL, McShane LM, Troendle JF, Rosenwald A and Simon R. Identifying pre-post chemotherapy differences in gene expression in breast tumors: a statistical method appropriate for this aim. British Journal of Cancer 86:1093-1096, 2002 • Radmacher MD, McShane LM and Simon R. A paradigm for class prediction using gene expression profiles. Journal of Computational Biology 9:505-511, 2002. • Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the analysis of DNA microarray data. Journal of the National Cancer Institute 95:14-18, 2003.

  12. Wright G, Simon R. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448-55, 2003 • Simon R. Using DNA microarrays for diagnostic and prognostic prediction, Expert Review of Molecular Diagnostics 3(5) 587-595, 2003 • Simon R. Diagnostic and prognostic prediction using gene expression profiles in high dimensional microarray data, British J Cancer 89:1599-1604, 2003 • Korn EL, Troendle JF, McShane LM, Simon R.Controlling the number of false discoveries. Journal of Statistical Planning and Inference 124:379-08, 2004 • Molinaro A, Simon R, Pfeiffer R. Prediction error estimation: A comparison of resampling methods. Bioinformatics 21:3301-7,2005. • Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 7:91, 2006.

  13. Dobbin K, Shih J, Simon R. Questions and answers on design of dual-label microarrays for identifying differentially expressed genes. Journal of the National Cancer Institute 95:1362-69, 2003 • Dobbin K, Shih J, Simon R. Statistical design of reverse dye microarrays. Bioinformatics 19:803-810, 2003 • Dobbin K, Simon R. Comparison of microarray designs for class comparison and class discovery, Bioinformatics 18:1462-69, 2002; 19:803-810, 2003; 21:2430-37, 2005; 21:2803-4, 2005 • Dobbin K and Simon R. Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics 6:27-38, 2005 • Dobbin K, Beer DG, Meyerson M, et al. Inter-laboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clinical Cancer Research 11:565-572, 2005 • Dobbin KK, Kawasaki ES, Petersen DW, and Simon RM. Characterizing dye bias in microarray experiments. Bioinformatics 21:2430-37, 2005 • Dobbin K and Simon R. Experimental design of DNA microarray studies. Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics. (L Jorde, P Little, M Dunn & S Subramaniam, eds). Wiley, 2005 • Dobbin K and Simon R. Sample size planning for developing classifiers using high dimensional DNA microarray data. Biostatistics (In Press).

  14. Using Genomic Classifiers In Clinical Trials • Simon R and Maitnourim A. Evaluating the efficiency of targeted designs for randomized clinical trials. Clinical Cancer Research 10:6759-63, 2004. • Maitnourim A and Simon R. On the efficiency of targeted clinical trials. Statistics in Medicine 24:329-339, 2005. • Simon R. When is a genomic classifier ready for prime time? Nature Clinical Practice – Oncology 1:4-5, 2004. • Simon R. An agenda for Clinical Trials: clinical trials in the genomic era. Clinical Trials 1:468-470, 2004. • Simon R. Development and Validation of Therapeutically Relevant Multi-gene Biomarker Classifiers. Journal of the National Cancer Institute 97:866-867, 2005. • Simon R. A roadmap for developing and validating therapeutically relevant genomic classifiers. Journal of Clinical Oncology 23:7332-41,2005. • Freidlin B and Simon R. Adaptive signature design. Clinical Cancer Research 11:7872-78, 2005. • Simon R. Validation of pharmacogenomic biomarker classifiers for treatment selection. Disease Markers (In Press). • Simon R. Guidelines for the design of clinical studies for development and validation of therapeutically relevant biomarkers and biomarker classification systems. In Biomarkers in Breast Cancer, Hayes DF and Gasparini G, pp 3-15, Humana Press, 2006.

  15. Using Genomic Classifiers In Clinical Trials • Simon R. and Wang SJ. Use of genomic signatures in therapeutics development in oncology and other diseases, The Pharmacogenomics Journal 6:166-73, 2006. • Simon R. A checklist for evaluating reports of expression profiling for treatment selection. Clinical Advances in Hematology and Oncology 4:219-224, 2006. • Trepicchio WL, Essayan D, Hall ST, Schechter G, Tezak Z, Wang SJ, Weinreich D, Simon R. Designing prospective clinical pharmacogenomic trials- Effective use of genomic biomarkers for use in clinical decision-making. The Pharmacogenomics Journal 6:89-94,2006. • Dupuy A and Simon R. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting, (Submitted for publication).

  16. BRB Websitehttp://linus.nci.nih.gov/brb • 15,000 hits per month • 702 hits to Technical Reports & Talks • 1985 hits to BRB-ArrayTools home page

  17. Statistically state-of-the-art integrated software for DNA microarray data analysis Architecture and statistical content by R Simon Programming by contractor User interface for use and education of biomedical scientists Publicly available for non-commercial use Active user list-serve and message board BRB-ArrayTools http://linus.nci.nih.gov/brb

  18. BRB-ArrayToolsJune 2006 • 6283 Registered users • 2000+ Distinct institutions • 62 Countries • 245 Citations • Registered users • 3528 in US • 456 at NIH • 246 at NCI

  19. NCI Support for Development of BRB-ArrayTools

  20. Possible Reasons for the Success of BRB Array Tools • It wasn’t designed by committee • It wasn’t a response to user’s dictating what should be developed. Few of our 6000 users really know what they needed, although most probably think that they do • It wasn’t developed in response to management decision of what was needed • It offers substance, not pro-forma software engineering • It offers correct approaches to data analysis in contrast to the vast majority of commercial and free software available

More Related